Management of recurrent medulloblastoma in adult patients: a systematic review and recommendations (Q38123365)

29 August 2017

title

Management of recurrent medulloblastoma in adult patients: a systematic review and recommendations (English)

1 reference

29 August 2017

0 references

1 reference

Xanthoula Kostaras

1

1 reference

29 August 2017

Jacob C Easaw

series ordinal

2

1 reference

29 August 2017

publication date

23 July 2013

1 reference

Journal of Neuro-Oncology

29 August 2017

published in

1 reference

29 August 2017

volume

115

1 reference

29 August 2017

issue

1

1 reference

29 August 2017

page(s)

1-8

1 reference

Review of the prognostic factors in medulloblastoma of children and adults.

29 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1206-3

Multivariate analysis of prognostic factors in adult patients with medulloblastoma. Retrospective study of 156 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1206-3

Long-term results of a prospective study on the treatment of medulloblastoma in adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1206-3

Adult medulloblastoma comprises three major molecular variants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1206-3

Molecular subgroups of medulloblastoma: the current consensus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1206-3

Medulloblastoma comprises four distinct molecular variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1206-3

Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1206-3

Common strategy for adult and pediatric medulloblastoma: a multicenter series of 253 adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1206-3

Is medulloblastoma the same tumor in children and adults?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1206-3

Survival and prognostic factors in a series of adults with medulloblastomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1206-3

The role of radiotherapy in adult medulloblastoma: long-term single-institution experience and a review of the literature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1206-3

Cure of recurrent medulloblastoma: the contribution of surgical resection at relapse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1206-3

Brain tumors across the age spectrum: biology, therapy, and late effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1206-3

Efficacy of vincristine and cyclophosphamide in the therapy of recurrent medulloblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1206-3

Combination chemotherapy in recurrent medulloblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1206-3

Treatment for recurrent medulloblastoma with intrathecal liposomal cytarabine and systemic metronomic combination therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1206-3

Temozolomide treatment of an adult with a relapsing medulloblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1206-3

Treatment of medulloblastoma with hedgehog pathway inhibitor GDC-0449

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1206-3

Improvement in survival produced by sequential therapies in the treatment of recurrent medulloblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1206-3

Reirradiation of primary CNS tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1206-3

Reirradiation for recurrent medulloblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1206-3

Re-irradiation of recurrent medulloblastoma--a case report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1206-3

Retreatment of recurrent adult medulloblastoma with radiotherapy: a case report and review of the literature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1206-3

Results of three-dimensional stereotactically-guided radiotherapy in recurrent medulloblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1206-3

Cerebral radionecrosis: Incidence and risk in relation to dose, time, fractionation and volume

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1206-3

Reirradiation of brain and skull base tumors with fractionated stereotactic radiotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1206-3

High-dose carboplatin, thiotepa, and etoposide with autologous stem cell rescue for patients with previously irradiated recurrent medulloblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1206-3

Possible benefits of high-dose chemotherapy and autologous stem cell transplantation for adults with recurrent medulloblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1206-3

Efficacy of High-dose Chemotherapy and Autologous Stem Cell Transplantation in Patients with Relapsed Medulloblastoma: A Report on The Korean Society for Pediatric Neuro-Oncology (KSPNO)-S-053 Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1206-3

Outcome of patients with recurrent medulloblastoma or central nervous system germinoma treated with low dose continuous intravenous etoposide along with dose-intensive chemotherapy followed by autologous hematopoietic stem cell rescue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1206-3

High-dose chemotherapy with autologous stem cell transplantation in adults with recurrent embryonal tumors of the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1206-3

High-dose chemotherapy with hematopoietic stem cell transplantation in adults with bone marrow relapse of medulloblastoma: report of two cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1206-3

High dose chemotherapy with stem-cell transplantation in a metastatic medulloblastoma in an adult: a case report and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1206-3

Treatment of recurrent metastatic medulloblastoma with intensive chemotherapy and allogeneic bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1206-3

Medulloblastoma in adults: a review of 47 patients treated between 1952 and 1981.

21 January 2018

1 reference

12 December 2020

Population-based study of medulloblastoma: outcomes in Alberta from 1975 to 1996.

1 reference

12 December 2020

Adult medulloblastoma: prognostic factors and patterns of relapse.

1 reference

12 December 2020

Severe encephalopathy after high-dose chemotherapy with autologous stem cell support for brain tumours

1 reference

12 December 2020

High-dose chemotherapy with autologous stem-cell rescue in patients with recurrent and high-risk pediatric brain tumors.

1 reference

12 December 2020

Antitumor effect of allogeneic hematopoietic SCT in metastatic medulloblastoma

1 reference

12 December 2020

Antiangiogenic therapy in the treatment of recurrent medulloblastoma in the adult: case report and review of the literature

1 reference

12 December 2020

High-dose carboplatin, thiotepa, and etoposide with autologous stem-cell rescue for patients with recurrent medulloblastoma. Children's Cancer Group

1 reference

12 December 2020

Survival and recurrence factors in adult medulloblastoma: the M.D. Anderson Cancer Center experience from 1978 to 1998

1 reference

12 December 2020

High dose chemotherapy with autologous stem cell rescue in adults with malignant primary brain tumors

1 reference

12 December 2020

10.1007/S11060-013-1206-3

Identifiers

DOI

1 reference

Dimensions Publication ID

29 August 2017

1041720753

0 references

1 reference